BG

Bellevue Group Portfolio holdings

AUM $4.81B
1-Year Est. Return 29.28%
This Quarter Est. Return
1 Year Est. Return
+29.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.2B
AUM Growth
+$793M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
228
New
Increased
Reduced
Closed

Top Buys

1
+$72M
2
+$48M
3
+$42.6M
4
ADPT icon
Adaptive Biotechnologies
ADPT
+$39.3M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$39M

Top Sells

1
+$238M
2
+$62.9M
3
+$45.4M
4
BMY icon
Bristol-Myers Squibb
BMY
+$41.5M
5
DVA icon
DaVita
DVA
+$39.6M

Sector Composition

1 Healthcare 96.41%
2 Industrials 0.94%
3 Technology 0.31%
4 Financials 0.04%
5 Consumer Discretionary 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$24.2M 0.24%
729,989
-12,211
102
$23.7M 0.23%
+352,021
103
$23.3M 0.23%
+525,000
104
$22.8M 0.22%
30,471
+13,423
105
$21.7M 0.21%
88,145
106
$21.6M 0.21%
122,000
+35,500
107
$21.2M 0.21%
41,974
+5,400
108
$18.3M 0.18%
280,863
109
$18.2M 0.18%
512,216
110
$17.3M 0.17%
2,602,858
111
$17.3M 0.17%
21,703
+2,310
112
$17.3M 0.17%
385,014
+6,011
113
$16M 0.16%
390,163
-213,080
114
$15.4M 0.15%
183,457
-15,000
115
$14.9M 0.15%
694,136
+239,562
116
$14.8M 0.14%
60,487
117
$14.6M 0.14%
241,046
+30,350
118
$14.4M 0.14%
48,989
+5,696
119
$13.6M 0.13%
148,871
-41,500
120
$13.4M 0.13%
160,148
+35,600
121
$12.6M 0.12%
96,507
122
$12.1M 0.12%
+507,930
123
$10.6M 0.1%
617,968
124
$10.1M 0.1%
159,129
125
$9.99M 0.1%
42,137
+25,608
3 4
5
6 7